ACTINOGEN MEDICAL LIMITED (ACW)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for ACW during the last 90 days, indicating Moderate trading activity

Latest ACW Signals
26/06/2026	SELL
31/03/2026	SELL
ACW Share Price
Current Price	$0.036
52 Week High	$0.070
52 Week Low:	$0.023
Trading at (% of 52 Week High)	51.43%

Business Overview

Actinogen Medical Limited (ASX: ACW) is a biotechnology company focused on developing treatments for neurodegenerative diseases, including Alzheimer's disease and cognitive impairment. The company specializes in drug candidates that target brain disorders by addressing underlying metabolic dysfunctions.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for ACW is supported by weak price performance and potential sector headwinds. However, limited liquidity and market volatility introduce some uncertainty, moderating the confidence level.

Latest  ACTINOGEN MEDICAL LIMITED(ACW)   News